Who
Wes Kaupinen
President and CEO
Company insider
Files Form 4 as: President and CEO, Palvella Therapeutics.
In numbers
- Trades disclosed
- 4
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 13 Dec 2024
- Last trade
- 5 Feb 2026
- Last filed
- 9 Feb 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 5 Feb 2026filed 9 Feb 2026 | PVLA Palvella Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —124,603 at $0.00 | filing |
| 5 Feb 2026filed 9 Feb 2026 | PVLA Palvella Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —124,603 at $0.00 | filing |
| 5 Feb 2025filed 10 Feb 2025 | PVLA Palvella Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —243,831 at $0.00 | filing |
| 13 Dec 2024filed 17 Dec 2024 | PVLA Palvella Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —417,806 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.